The company has issued more shares over this period, which dilutes each existing shareholder’s stake.
Diluted shares outstanding: 5.8M (2021) → 41.9M (2025)
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
+2.9% YoY
YoY Growth Rate
Slow revenue growth
+16.3% YoY
YoY Growth Rate
Steady EPS growth
$7M/ year
↑ Rising (+46% vs prior year)
17.0% of revenue
In line with sector average (18%)
Investing heavily in future products and technology
~19 months
$16M cash & investments
Quarterly Free Cash Flow
↓ Burn rate worsening
Adequate runway but may need to raise capital within 2 years
Myomo is putting 17% of revenue into R&D and that number is rising.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
Negative ROIC means the business is losing money on every dollar invested in it.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Free cash flow is negative. They are burning cash, not generating it.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
